Share chart Generation Bio Co.
Extended chart
Simple chart
About Generation Bio Co.
Generation Bio Co., компания по производству генетических лекарств, разрабатывает генную терапию для лечения редких и распространенных заболеваний. Компания разрабатывает портфель из восьми программ для лечения редких и распространенных заболеваний печени и сетчатки. Она также фокусируется на заболеваниях скелетных мышц, центральной нервной системы и онкологии. Компания ранее была известна как Torus Therapeutics, Inc. и сменила свое название на Generation Bio Co. в ноябре 2017 года. Generation Bio Co. была основана в 2016 году со штаб-квартирой в Кембридже, штат Массачусетс.| IPO date | 2020-06-12 |
|---|---|
| ISIN | US37148K1007 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | http://generationbio.com |
| Цена ао | 0.4733 |
| Change price per day: | 0% (0.4733) |
|---|---|
| Change price per week: | -12.9% (0.5434) |
| Change price per month: | -21.64% (0.604) |
| Change price per 3 month: | -55.77% (1.07) |
| Change price per half year: | -79.6% (2.32) |
| Change price per year: | -87.21% (3.7) |
| Change price per 3 year: | -94.59% (8.75) |
| Change price per year to date: | -55.77% (1.07) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8279484 | 12.45 |
| Price (T.Rowe) Associates Inc | 6926174 | 10.42 |
| FMR, LLC | 5352399 | 8.05 |
| Bellevue Group AG | 3617080 | 5.44 |
| Blackrock Inc. | 3168415 | 4.77 |
| Artal Group S.A. | 2814191 | 4.23 |
| Vanguard Group Inc | 2552251 | 3.84 |
| Bank of America Corporation | 2527862 | 3.8 |
| EcoR1 Capital, LLC | 2046867 | 3.08 |
| PFM Health Sciences, LP | 1622487 | 2.44 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.03478 | 17.09 | 1.54048 |
| Avantis U.S Small Cap Equity ETF | 0.00679 | 27.77 | 1.68271 |
Schwab U.S. Small-Cap ETF
|
0.00323 | 17.47 | 1.51433 |
ProShares UltraPro Russell2000
|
0.00297 | 89.82 | 1.47873 |
| ProShares Hedge Replication ETF | 0.00078 | 5.92 | 1.47892 |
| Dimensional U.S. Targeted Value ETF | 0.00074 | 26.01 | 1.93487 |
| iShares Russell 3000 ETF | 0.0004 | 24.83 | 1.43482 |
Schwab U.S. Broad Market ETF
|
0.00029 | 24.86 | 1.43354 |
| Vanguard Russell 2000 ETF | 0 | 17.16 | 1.48801 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| 0 | 28.28 | 1.54 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Matthew Norkunas M.B.A., M.D. | Chief Financial Officer | 611.11k | 1978 (47 years) |
| Dr. Robert Kotin Ph.D. | Co-Founder | N/A | 1956 (69 years) |
| Dr. Matthew Stanton Ph.D. | Chief Scientific Officer | 654.83k | 1973 (52 years) |
| Dr. Mark D. Angelino Ph.D. | Co-Founder | N/A | 1973 (52 years) |
| Dr. Cameron Geoffrey McDonough M.D. | President, CEO & Director | 939.09k | 1970 (55 years) |
| Ms. Jasmin Tower | Chief Human Resources Officer | N/A | |
| Ms. Antoinette Paone M.B.A., M.S. | Chief Operating Officer | N/A | 1978 (47 years) |
| Ms. Yalonda Howze J.D. | Chief Legal Officer & Secretary | N/A | 1972 (53 years) |
| Dr. Phillip Samayoa Ph.D. | Chief Strategy Officer | N/A | 1987 (38 years) |
Address: United States, Cambridge, MA , 301 Binney Street - open in Google maps, open in Yandex maps
Website: http://generationbio.com
Website: http://generationbio.com
